Mercer Global Advisors’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $509K | Sell |
7,200
-5,134
| -42% | -$277K | ﹤0.01% | 2277 |
|
|
2026
Q1 | $645K | Buy |
12,334
+908
| +8% | +$54.5K | ﹤0.01% | 1811 |
|
|
2025
Q4 | $672K | Buy |
11,426
+125
| +1% | +$7.59K | ﹤0.01% | 1676 |
|
|
2025
Q3 | $629K | Buy |
11,301
+6,741
| +148% | +$361K | ﹤0.01% | 1624 |
|
|
2025
Q2 | $235K | Buy |
4,560
+441
| +11% | +$22.2K | ﹤0.01% | 2000 |
|
|
2025
Q1 | $241K | Buy |
4,119
+91
| +2% | +$6.17K | ﹤0.01% | 1865 |
|
|
2024
Q4 | $290K | Sell |
4,028
-751
| -16% | -$55.1K | ﹤0.01% | 1776 |
|
|
2024
Q3 | $374K | Sell |
4,779
-774
| -14% | -$58.2K | ﹤0.01% | 1510 |
|
|
2024
Q2 | $446K | Buy |
5,553
+872
| +19% | +$64.2K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $331K | Buy |
4,681
+462
| +11% | +$33.1K | ﹤0.01% | 1509 |
|
|
2023
Q4 | $326K | Sell |
4,219
-324
| -7% | -$21.3K | ﹤0.01% | 1558 |
|
|
2023
Q3 | $309K | Sell |
4,543
-161
| -3% | -$12.7K | ﹤0.01% | 1520 |
|
|
2023
Q2 | $384K | Sell |
4,704
-2,123
| -31% | -$171K | ﹤0.01% | 1364 |
|
|
2023
Q1 | $506K | Sell |
6,827
-630
| -8% | -$48.6K | ﹤0.01% | 1196 |
|
|
2022
Q4 | $618K | Sell |
7,457
-2,271
| -23% | -$180K | ﹤0.01% | 1113 |
|
|
2022
Q3 | $691K | Sell |
9,728
-1,860
| -16% | -$161K | ﹤0.01% | 1003 |
|
|
2022
Q2 | $1M | Sell |
11,588
-4,108
| -26% | -$385K | 0.01% | 842 |
|
|
2022
Q1 | $1.7M | Buy |
15,696
+1,020
| +7% | +$105K | 0.01% | 698 |
|
|
2021
Q4 | $1.9M | Buy |
14,676
+728
| +5% | +$89.2K | 0.01% | 645 |
|
|
2021
Q3 | $1.69M | Sell |
13,948
-564
| -4% | -$68.6K | 0.01% | 668 |
|
|
2021
Q2 | $1.63M | Buy |
14,512
+196
| +1% | +$20.6K | 0.01% | 646 |
|
|
2021
Q1 | $1.37M | Sell |
14,316
-376
| -3% | -$34.3K | 0.01% | 678 |
|
|
2020
Q4 | $1.17M | Buy |
14,692
+5,128
| +54% | +$371K | 0.01% | 563 |
|
|
2020
Q3 | $592K | Buy |
9,564
+268
| +3% | +$17.4K | 0.01% | 723 |
|
|
2020
Q2 | $614K | Sell |
9,296
-652
| -7% | -$39K | 0.01% | 613 |
|
|
2020
Q1 | $472K | Sell |
9,948
-4,808
| -33% | -$241K | 0.01% | 673 |
|
|
2019
Q4 | $810K | Sell |
14,756
-3,204
| -18% | -$168K | 0.02% | 583 |
|
|
2019
Q3 | $878K | Sell |
17,960
-1,480
| -8% | -$74.2K | 0.02% | 529 |
|
|
2019
Q2 | $1.01M | Sell |
19,440
-308
| -2% | -$15.5K | 0.03% | 458 |
|
|
2019
Q1 | $980K | Buy |
+19,748
| New | +$889K | 0.04% | 422 |
|
Other funds holding TECH
HI
Mercer Global Advisors's TECH Position: Q2 2026 in Review
Mercer Global Advisors reduced its Bio-Techne (TECH) stake by 42% in Q2 2026, selling an estimated $277K and leaving 7,200 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.
Mercer Global Advisors first reported a position in TECH in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.9M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Mercer Global Advisors held 7,200 shares of Bio-Techne worth $509K as of Q2 2026.
- Mercer Global Advisors sold 5,134 Bio-Techne shares in Q2 2026, an estimated $277K.
- Bio-Techne made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2277 holding.
- Mercer Global Advisors first reported a position in Bio-Techne in Q1 2019 and has held it in 30 quarters since.
- Mercer Global Advisors's Bio-Techne position peaked at $1.9M in Q4 2021.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.